There is a clinical need for objective evidence-based measures that are sensitive and specific to ADHD when compared with other neurodevelopmental disorders. This study evaluated the incremental validity of adding an objective measure of activity and computerised cognitive assessment to clinical rating scales to differentiate adult ADHD from Autism spectrum disorders (ASD).
impulsivity with a motion-tracking infra-red camera to measure activity (hyperactivity) during test completion. Sensitivity of the measures to ADHD has been reported in affected individuals (Edebol et al., 2013) and at-risk siblings (Reh et al., 2014) and there is also evidence of sensitivity to medication response in adults (Bijlenga et al., 2015) . However no research has investigated the specificity of the test in adult ADHD when compared with adult ASD. It is important to investigate the potential clinical utility and incremental validity of QbTest because, despite a weak evidence base, it has already been introduced into clinical practice in a number of healthcare clinics in the United Kingdom (U.K.) and Europe. Further research is therefore urgently needed to evaluate the utility of QbTest as an aid to diagnostic decision-making in the assessment of ADHD.
The aim of the present study was to determine whether QbTest aids the differentiation of adult ADHD from ASD when combined with brief, standardised clinical rating scales, as part of a full clinical assessment. We predicted that adding QbTest to brief clinical rating scales for ADHD (CAARS) and autism (AQ10) would show incremental validity with significantly improved distinction between ADHD and ASD, and compared with using clinical rating scales alone.
Methods

Participants
Thirty-seven adults aged 18 to 60 years with a DSM-IV diagnosis of ADHD (24 males; mean age 30.46 ± SD 10) years and 25 adults aged 19 to 47 years with a ICD10 diagnosis of Asperger's Syndrome (19 males, mean age 33.22 ± SD 11.74 years) were recruited to the study. Participation in the study was voluntary and signed consent was obtained for all participants. Ethical approval for the study was granted by the local Research diagnosis of Asperger's Syndrome. Of 34 service-users who consented to participate, 1 failed to complete the QbTest and 8 were excluded due to comorbid ADHD, leaving a final sample of 25 participants.
All diagnoses used ICD-10 criteria other than for ADHD where DSM-5 criteria were used, as is accepted practice in the UK. Comorbid diagnoses in the ADHD group included ICD-10 diagnoses of depression (2), anxiety disorder (2) and emotionally unstable personality disorder (equivalent to DSM-5 borderline personality disorder) (2). Within the ASD group, ICD-10 comorbid diagnoses included anxiety (4), depression (2), anxiety and depression (1), bipolar disorder (1) and substance misuse (1). Any participants taking prescribed psychostimulant medication were asked to abstain for 24 hours before assessment as these medications would ameliorate performance deficits on QbTest.
Measures
Self-report clinical measures
The CAARS (Conners et al., 1999) is an 18-item questionnaire with a 5-point rating scale to measure ADHD symptoms over the preceding 6 months. It comprises 5 sub-scales:
A-Inattention/Memory; B-Hyperactivity/Restlessness, C-Impulsivity/Emotional Lability, DSelf-Concept, E-ADHD Index. The scale is used extensively in clinical practice and research and has good test-re-test reliability and high sensitivity and specificity (Erhardt et al., 1999) .
The Autism Quotient-10 (AQ-10; Allison et al., 2012; Baron-Cohen et al., 2001 ) is a ten-item self-report questionnaire with the purpose of screening for possible autism spectrum disorders. Responses are made on a scale and a total score is yielded. A score of 6 or above is potentially indicative of ASD. The scale has high sensitivity and specificity (Allison et al., 2012) .
QbTest
The QbTest is a computerised CPT coupled with an infra-red motion tracking system.
There are two versions of the test: QbTest (6-12) and QbTest (12+) with the latter designed specifically to avoid potential ceiling effects in adolescents and adults (ages 12+). The CPT for ages 12+ was used in the present study. The test comprises 600 stimuli presented sequentially and centrally on a computer screen in pseudorandom order for 200ms each with an inter stimulus interval (ISI) of 2000ms. Stimuli are blue or red squares and circles.
Participants are required to press a hand-held responder button when an on-screen stimulus matches in colour (blue or red) and shape (square or circle) with the previous stimulus (targets) and to withhold the response when the stimuli do not match. Of the total presented stimuli 150 (25%) are targets. Speed and accuracy are equally encouraged. The task lasts approximately 20 minutes and is preceded by a 5-minute practice session which includes standardised on-screen instructions. Measurement of hit rate (proportion of correctly responded to targets), Reaction Time (RT) to targets and RT variability (standard deviation of RT) give an index of attention while the proportion of commission errors (incorrect responses to non-targets) gives an index of impulsivity. The motion-tracking system is an infra-red camera placed 1 metre from the participant which captures movement by tracking a reflective headband worn by the participant. Activity is recorded throughout the CPT by recording the location of the marker on the headband on x-y co-ordinates, at a frequency of 50 samples per second and with a spatial resolution of 1/27mm per infrared camera unit. Summary scores ('q-scores') in each of these domains (labelled Q-Activity, Q-Inattention, Q-Impulsivity) are obtained for each individual by transforming the raw data into units of standard deviation from the mean of an age-and gender-stratified normative sample, after correcting for skew.
Q-scores are therefore equivalent to z-scores (Ulberstad, 2012) and higher Q-scores indicate greater risk of ADHD. To provide an index equivalent to the CAARS-E ADHD Index and to reduce the number of variables entered into regression analysis (see 2.4) a composite QbTest measure (QbTotal) was computed by calculating the mean of the 3 'cardinal' Q-score parameters.
Procedure
The QbTest took place in each clinic and was conducted by a fully trained research assistant (ZY). All participants watched a short instruction video. The researcher checked their understanding of the test verbally and by monitoring performance during the standardised practice test. All participants completed the CAARS, AQ10 and QbTest immediately before their clinic appointment.
Data Analysis
To provide an overview of group differences on the QbTest, CAARS and ASD, the ADHD and ASD groups were compared on each of the QbTest cardinal parameters (QActivity, Q-Inattention, Q-Impulsivity), QbTotal, the 5 CAARS sub-scales (A to E) and the AQ10 using univariate ANOVA. To reduce type 1 error rate a Bonferroni corrected p-value of .005 (alpha .05/10) was applied.
To determine whether QbTest improves the differentiation of ADHD from ASD when added to CAARS and AQ10, binary logistic regression was performed to measure the probability of assignment to the ADHD or ASD group (dependent variable), based on scores on the CAARS-E, AQ10 and QbTest (predictor variables). To ensure a good case variable ratio given the total sample size, the CAARS-E subscale ('ADHD Index') was used rather than all subscales and the QbTest composite score, QbTotal, was used as an equivalent to CAARS-E. Composite measures also offer greater practical value in a clinical setting by providing a simple summary score. These variables were entered into logistic regression in two steps with CAARS-E and AQ10 entered simultaneously in the first step and QbTotal entered into the second step. This order was chosen as the most sensible to address the question of whether QbTest improves the sensitivity and specificity afforded by brief clinical rating scales. At each step, the goodness of fit of the model was evaluated with chi-square with a significance threshold of .05. In addition, the percentage of participants correctly assigned to the ADHD group and to the ASD group was evaluated to determine the sensitivity and specificity of the model. Tolerance statistics indicated no multi-collinearity between the variables included in the model. After examining leverage values one participant in the ADHD group was excluded from the analysis. To determine whether the model was robust to the order in which the individual predictors were entered, the order of entry of the predictors was reversed and resulted in the same final classification.
Receiver Operating Characteristic (ROC) curves were calculated for each predictor variable related to ADHD diagnosis (CAARS-E, QbTotal) to determine which offered the best sensitivity and specificity to ADHD and to identify associated cut-off scores on each measure.
Results
As shown in Table 1 , the ADHD and ASD groups were well-matched on age and gender distribution. Q-scores (reflecting deviation from a normative sample in standardised units) were significantly greater in the ADHD than ASD group on all QbTest cardinal parameters but Q-Impulsivity did not meet the Bonferroni-corrected threshold. The groups also differed significantly on all sub-scales of the CAARS except CAARS-D (Self-Concept), although the difference on CAARS-A Inattention/Memory did not survive correction. The ASD group scored significantly higher on the AQ10.
[Insert Table 1 here] To determine whether adding QbTotal enhanced the sensitivity and specificity of identifying ADHD when combined with the CAARS-E ADHD Index and AQ10 alone, these variables were entered, stepwise, into binary logistic regression with Group (ADHD, ASD) as the dependent variable. The goodness of fit of the model at the first step with CAARS-E and AQ10 entered as predictors was highly significant (χ 2 = 31.59, p < .001) yielding group classification accuracy of 81% (84% sensitivity, 76% specificity, see Table 2 ) and explaining 57% of variance in the data (Nagelkerke R 2 =.57). CAARS-E (Wald = 11.21, p <.01; Exp (β) = 1.19, 95% CI = 1.07, 1.32) and AQ10 were both significant predictors (Wald = 9.78, p <.01; Exp (β) = .46, 95% CI = .28, 75).
In step 2 QbTotal was added to the model and led to a highly significant improvement in model fit ( Step χ 2 = 14.11, p <.001, Model χ 2 = 45.69, p <.001) with 74% of variance in the data explained (Nagelkerke R 2 = .74) and overall classification accuracy of 90% (94% sensitivity, 84% specificity). CAARS-E (Wald = 6.21, p<.05, Exp (β) = 1.18, 95% CI = 1.04, 1.33) and AQ10 (Wald = 9.26, p <.01, Exp (β) = .42, 95% CI = .24, .74) remained significant and QbTotal was also significant (Wald = 8.95, p<.01, Exp (β) = 6.50, 95% CI = 1.91,
22.17). Detailed figures on the assignment of participants to either the ADHD or ASD
groups at each step of the analysis are shown in Table 2 .
[Insert Table 2 here] ROC curves were computed for CAARS-E and QbTotal and the Area Under the Curve (AUC) was calculated. As shown in Figure 1 , QbTotal yielded the highest AUC value, .87 (classified as 'good') while the value for CAARS-E was .77 ('fair'). The ROCs indicate that at equivalent sensitivity of around .8, QbTotal demonstrates superior specificity compared with CAARS-E. On the CAARS-E, sensitivity of .84 and specificity of .60 corresponds to a T-score of 69. On QbTotal, sensitivity of .84 and specificity of .80 corresponds to a Q-score of 1.12.
identified a Q-score of 1.12 associated with 84% sensitivity and 80% specificity to ADHD, suggesting that this may be a useful cut-off predictive of ADHD when the sample comprises individuals with ADHD and ASD diagnoses.
It should be noted that although statistically significant, the improvements in the model with QbTest added are fairly modest and do not yield perfect results. Thus, although these findings offer some promise for the use of a computerised cognitive test to augment routine clinical diagnostic assessment, future research is needed to assess their reliability and generalisability and to determine the stability of the putative cut-off score for ADHD. In particular, further evidence is needed to help clinicians and healthcare service managers decide whether adding QbTest to clinical assessment of ADHD is cost effective. A recent audit reported that adding QbTest to ADHD assessment in a child and adolescent service reduced time to diagnosis and resulted in cost savings (Hall et al., 2016) . Although these results offer some promise, further research is needed to determine how best to implement the test to enhance diagnostic decision-making in a cost-effective way.
It is noteworthy that the univariate group ANOVA effects for Q-Impulsivity and CAARS-Inattention failed to reach statistical significance after correction for multiple comparisons. This suggests that these measures perform less well in differentiating between ADHD and ASD than the other parameters. Furthermore, the mean Q-Activity score of 2.81 in the ADHD group indicates significant rates of activity in this adult group. This is consistent with previous evidence (Lis et al., 2010) and suggests that when compared against a large normative database (Ulberstad, 2012) , hyperactivity is still present in adulthood in ADHD. The relatively small sample size of the present study prevented inclusion of the individual QbTest parameters and CAARS subscales in logistic regression. A further question leading on from the present findings is therefore whether the individual parameters on QbTest offer greater sensitivity and specificity compared with the composite measures used here. In particular, it would be useful to determine whether the Q-Activity parameter is effective in differentiating the Combined and Inattentive ADHD sub-types. The present study sample comprised mostly adults with the Combined sub-type and so this important question could not be addressed here. Further research could also examine relationships between the movement and attention parameters recorded by QbTest as there is evidence to suggest that increases in activity may be intimately related to fluctuations in attention (Licht et al., 2009 ).
Certain limitations should be considered when interpreting the results. Firstly, the research was limited to two specialist adult neurodevelopmental clinics in Nottinghamshire, U.K. Although there is no reason to consider the participants or clinics were not representative of other specialist ADHD or Asperger's clinics, care should be taken when generalising these findings to other sectors of the ADHD or ASD populations. In particular, all those in the ASD group were diagnosed with Asperger's Syndrome and were therefore relatively high functioning and in the ADHD group, the majority were combined sub-type.
Secondly, in this study, we first sought to see if QbTest could aid the differentiation of two neurodevelopmental diagnoses. In real-world clinical practice however, differential diagnoses with adult ADHD are often complex with other co-occurring disorders being considered (e.g. bipolar disorder or antisocial personality disorder). One previous study suggests QbTest may fare less well when samples are more heterogeneous (Söderström et al., 2014) . It will also be important to determine whether the impressive sensitivity and specificity parameters reported here are upheld in a sample that includes comorbid ADHD/ASD cases.
To conclude, the findings presented here suggest that adding a computerised cognitive assessment to frequently used standard clinical rating scales of ADHD and ASD improves correct diagnostic classification of these two neurodevelopmental disorders in adults. Further work is needed to replicate these findings in larger, more diverse samples and to evaluate the benefits and costs of including QbTest in clinical assessment. It will be important to further establish an evidence base for this measure which has already been introduced into some clinics.
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